151 related articles for article (PubMed ID: 30717118)
1. Understanding Implementation Challenges to Genetic Testing for Familial Hypercholesterolemia in the United States.
Hendricks-Sturrup RM; Lu CY
J Pers Med; 2019 Feb; 9(1):. PubMed ID: 30717118
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Integrating Patient-Reported Outcomes Into Clinical Genetic Testing for Familial Hypercholesterolemia.
Hendricks-Sturrup RM; Block R; Lu CY
J Patient Cent Res Rev; 2021; 8(4):336-339. PubMed ID: 34722802
[TBL] [Abstract][Full Text] [Related]
4. Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review.
Hendricks-Sturrup RM; Mazor KM; Sturm AC; Lu CY
J Pers Med; 2019 Jul; 9(3):. PubMed ID: 31266140
[TBL] [Abstract][Full Text] [Related]
5. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
Trinder M; Li X; DeCastro ML; Cermakova L; Sadananda S; Jackson LM; Azizi H; Mancini GBJ; Francis GA; Frohlich J; Brunham LR
J Am Coll Cardiol; 2019 Jul; 74(4):512-522. PubMed ID: 31345425
[TBL] [Abstract][Full Text] [Related]
6. Effects of Genetic Variants Associated with Familial Hypercholesterolemia on Low-Density Lipoprotein-Cholesterol Levels and Cardiovascular Outcomes in the Million Veteran Program.
Sun YV; Damrauer SM; Hui Q; Assimes TL; Ho YL; Natarajan P; Klarin D; Huang J; Lynch J; DuVall SL; Pyarajan S; Honerlaw JP; Gaziano JM; Cho K; Rader DJ; O'Donnell CJ; Tsao PS; Wilson PWF
Circ Genom Precis Med; 2018 Dec; 11(12):. PubMed ID: 31106297
[TBL] [Abstract][Full Text] [Related]
7. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
[TBL] [Abstract][Full Text] [Related]
8. An Implementation Science Framework to Develop a Clinical Decision Support Tool for Familial Hypercholesterolemia.
Bangash H; Pencille L; Gundelach JH; Makkawy A; Sutton J; Makkawy L; Dikilitas O; Kopecky S; Freimuth R; Caraballo PJ; Kullo IJ
J Pers Med; 2020 Jul; 10(3):. PubMed ID: 32717811
[TBL] [Abstract][Full Text] [Related]
9. Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach.
Jones LK; Calvo EM; Campbell-Salome G; Walters NL; Brangan A; Rodriguez G; Ahmed CD; Morgan KM; Gidding SS; Williams MS; Brownson RC; Seaton TL; Goldberg AC; McGowan MP; Rahm AK; Sturm AC
Front Health Serv; 2023; 3():1104311. PubMed ID: 37188259
[TBL] [Abstract][Full Text] [Related]
10. Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia.
Sarraju A; Knowles JW
Front Cardiovasc Med; 2019; 6():5. PubMed ID: 30761309
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
[TBL] [Abstract][Full Text] [Related]
12. New Approaches in Detection and Treatment of Familial Hypercholesterolemia.
Hartgers ML; Ray KK; Hovingh GK
Curr Cardiol Rep; 2015 Dec; 17(12):109. PubMed ID: 26482752
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
Chen CX; Hay JW
Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
[TBL] [Abstract][Full Text] [Related]
14. Autosomal recessive hypercholesterolemia: Case report.
Petrulioniene Z; Gargalskaite U; Mikstiene V; Norvilas R; Skiauteryte E; Utkus A
J Clin Lipidol; 2019; 13(6):887-893. PubMed ID: 31734096
[TBL] [Abstract][Full Text] [Related]
15. Toward a new clinical classification of patients with familial hypercholesterolemia: One perspective from Spain.
Masana L; Ibarretxe D; Rodríguez-Borjabad C; Plana N; Valdivielso P; Pedro-Botet J; Civeira F; López-Miranda J; Guijarro C; Mostaza J; Pintó X;
Atherosclerosis; 2019 Aug; 287():89-92. PubMed ID: 31238171
[TBL] [Abstract][Full Text] [Related]
16. DNA testing for familial hypercholesterolemia: improving disease recognition and patient care.
Vergopoulos A; Knoblauch H; Schuster H
Am J Pharmacogenomics; 2002; 2(4):253-62. PubMed ID: 12421096
[TBL] [Abstract][Full Text] [Related]
17. The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.
Hooper AJ; Burnett JR; Bell DA; Watts GF
Curr Atheroscler Rep; 2018 May; 20(6):31. PubMed ID: 29779130
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
[TBL] [Abstract][Full Text] [Related]
19. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
